Biora is the biotech company reimagining therapeutic delivery.
By creating innovative smart pills designed for targeted drug delivery to the GI tract and systemic, needle-free delivery of biotherapeutics, we are developing therapies to improve patients’ lives.
To develop innovative smart-pill technologies that improve patients’ lives.
At Biora, we are on a mission to reimagine therapeutics and their delivery.
We envision a world where all patients have access to needle-free drug delivery and better therapeutic outcomes.
Our company was founded in 2010 as Ascendant MDx, Inc., and changed its name in 2013 to Progenity, Inc. Our initial public offering was June 19, 2020. In 2021, the company underwent a strategic transformation to focus on our innovative therapeutics pipeline, and in 2022 we became Biora Therapeutics, Inc.
We are currently focused on developing therapeutics technologies that improve patients’ lives, through a revolutionary combination of drug therapies and smart capsule technology.
Connect with us